http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2309753-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_76b8a3f04c31ad85cb89de8ee422f3bb |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00 |
| filingDate | 2006-05-05^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2007-11-10^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06ea053cbe41a7858aecdcda27d28d40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a4a257378c91ee07f76fe7dc5ee1bb0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e929ef3472d535965261d07ebf96625a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_227267596474356bbcd8ef058b627a8b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53c10cfb95eb8dc25b9167c12692c680 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44c5fa7b77d76774f6989841e1b0eae6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14f078d966d2ef3e227112dd7af56094 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec04ae2ea48d0fab861ffc9d74714998 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f0e3abc93c0dbfe05ee47deff97ee81 |
| publicationDate | 2007-11-10^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2309753-C1 |
| titleOfInvention | Combined cell transplant based on lymphokine-activated killers and dendrite cells, method for production thereof and method for treatment and prophylaxis of malignant, infective diseases and immunodeficient conditions |
| abstract | FIELD: biopharmacology and medicine. n SUBSTANCE: disclosed is method for production of mononuclear blood cells, namely activated lymphocytes (ACL) and dendrite cells (DC). Claimed method includes a) isolation of mononuclear leucocytes (MNL) from blood and marrow of patient suffering from malignant neoplasm, or infective disease, or immunodeficient condition; d) incubation of isolated mononuclear lymphocytes in cultural medium; c) separation of MNL cultural bottles adhering to plastic and non-adhering thereto.; d) treatment of adhering MNL with growth factors to produce dendrite cells therefrom; e) treatment of DC with lysates from patient tumor; f) cultivation of non-adhered lymphocytes with interleukine-2 to produce ACL-cells. Also disclosed is method for treatment and prophylaxis malignant and infective diseases and immunodeficient conditions in patients by combined application of ACL-cells and dendrite cells. n EFFECT: new method for treatment and prophylaxis of malignant, infective diseases and immunodeficient conditions. n 3 cl |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2577992-C2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2578008-C1 |
| priorityDate | 2006-05-05^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 1000 of 1038.
| Next Page | Last Page |